Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Shanghai Generon Initiates a Phase II Trial for Breast Cancer in the US

publication date: May 9, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Shanghai Generon announced that it will initiate a randomized, multi-center Phase 2 clinical trial in the US in breast cancer patients receiving myelotoxic chemotherapy. The company believes F-627 is one of the first innovative biologic drug candidates developed by a Chinese biotech company to enter global clinical development. More details…

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners